Cardiovascular disease and COVID-19: a consensus paper from the ESC working group on coronary pathophysiology & microcirculation, ESC working group on …

E Cenko, L Badimon, R Bugiardini… - Cardiovascular …, 2021 - academic.oup.com
The cardiovascular system is significantly affected in coronavirus disease-19 (COVID-19).
Microvascular injury, endothelial dysfunction, and thrombosis resulting from viral infection or …

ESC guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 2—care pathways, treatment, and follow-up

Cardiovascular Research, 2022 - academic.oup.com
Aims Since its emergence in early 2020, the novel severe acute respiratory syndrome
coronavirus 2 causing coronavirus disease 2019 (COVID-19) has reached pandemic levels …

Role of Hypertension on the Severity of COVID-19: A Review

M Peng, J He, Y Xue, X Yang, S Liu… - Journal of …, 2021 - journals.lww.com
The novel coronavirus disease (COVID-19) caused by the severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) has rapidly evolved into a global pandemic. The …

European Society of Cardiology guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 1—epidemiology …

Task Force for The Management of COVID … - Cardiovascular …, 2022 - academic.oup.com
Aims Since its emergence in early 2020, the novel severe acute respiratory syndrome
coronavirus 2 causing coronavirus disease 2019 (COVID-19) has reached pandemic levels …

Hypertension and COVID-19: current evidence and perspectives

G Gallo, V Calvez, C Savoia - High Blood Pressure & Cardiovascular …, 2022 - Springer
Abstract Coronavirus disease 2019 (COVID-19) outbreak, caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), represents a real challenge for health …

[PDF][PDF] A diabetic milieu increases ACE2 expression and cellular susceptibility to SARS-CoV-2 infections in human kidney organoids and patient cells

E Garreta, P Prado, ML Stanifer, V Monteil, A Marco… - Cell Metabolism, 2022 - cell.com
It is not well understood why diabetic individuals are more prone to develop severe COVID-
19. To this, we here established a human kidney organoid model promoting early hallmarks …

Hypertension, a moving target in COVID-19: current views and perspectives

C Savoia, M Volpe, R Kreutz - Circulation Research, 2021 - Am Heart Assoc
Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) associates with a considerable high rate of mortality and …

[HTML][HTML] COVID-19 and hypertension: the what, the why, and the how

SA Muhamad, A Ugusman, J Kumar, D Skiba… - Frontiers in …, 2021 - frontiersin.org
It has been a year since the coronavirus disease 2019 (COVID-19) was declared pandemic
and wreak havoc worldwide. Despite meticulous research has been done in this period …

Renin‐angiotensin system inhibitors in patients with COVID‐19: a meta‐analysis of randomized controlled trials led by the international society of hypertension

SR Gnanenthiran, C Borghi, D Burger… - Journal of the …, 2022 - Am Heart Assoc
Background Published randomized controlled trials are underpowered for binary clinical
end points to assess the safety and efficacy of renin‐angiotensin system inhibitors (RASi) in …

Uncovering genetic mechanisms of hypertension through multi-omic analysis of the kidney

JM Eales, X Jiang, X Xu, S Saluja, A Akbarov… - Nature …, 2021 - nature.com
The kidney is an organ of key relevance to blood pressure (BP) regulation, hypertension and
antihypertensive treatment. However, genetically mediated renal mechanisms underlying …